Morgan Stanley (MS) Research & Development (2009 - 2026)

Morgan Stanley (MS) has reported Research & Development for 18 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development rose 9.33% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $4.5 billion (up 8.51% YoY), while the FY2025 annual figure was $4.4 billion, up 8.07% from the prior year.
• Research & Development slipped to $1.1 billion in Q1 2026 per MS's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Research & Development topped out at $1.2 billion in Q4 2025 and bottomed at $829.0 million in Q1 2022.
• Historically, Research & Development has averaged $995.4 million across 5 years, with a median of $987.0 million in 2023.
• Annual changes were most pronounced in 2022 — Research & Development rose 13.1% — and 2023, when it increased 5.79%.
• Morgan Stanley's Research & Development stood at $933.0 million in 2022, then gained by 5.79% to $987.0 million in 2023, then advanced by 7.29% to $1.1 billion in 2024, then climbed by 9.54% to $1.2 billion in 2025, then decreased by 1.03% to $1.1 billion in 2026.
• Business Quant data shows MS's Research & Development at $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.1 billion in Q3 2025.